Analisis Farmakoekonomi (Cost Effectiveness Analysis) Penggunaan Terapi Infus Imunoglobulin Intravena (IVIG) Pada Kasus Coronary Virus Disease (Covid-19)
Issaura Issaura(1*), Novianti Fatli Azizah(2), Renny Nurul Faizah(3), Ika Putri Jami'atusholihah(4), Shafinaz Nabila Rahmania(5)
(1) Rumah Sakit Umum Daerah Sidoarjo
(2) Rumah Sakit Umum Daerah Sidoarjo
(3) Rumah Sakit Umum Daerah Sidoarjo
(4) Rumah Sakit Umum Daerah Sidoarjo
(5) Rumah Sakit Umum Daerah Sidoarjo
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Blackford, M.G., Glover, M.L., and Reed, M.D., 2016. Lower respiratory tract infection. In: Dipiro, J.T., Talbert R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey,L.M., (Eds.). Pharmacotherapy a Pathophysiologic Approach, Ed. 7th, America: The Mc Graw-Hill, pp. 4733-88.
Cao, W., Liu, X., Bai, T., Fan, H., Hong, K., Song, H., Han, Y., Lin, L., Ruan, L., and Li, T., 2020. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Disease, pp.1-6.
Centers for Disease Control and Prevention (CDC). 2020. Coronavirus Disease 2019 (COVID-19):OlderAdults.Diaksesdarihttps://www.cdc.gov/coronavirus/2019- ncov/need-extra-precautions/older-adults.html, pada tanggal 15 November2020.
Fang, L., Karakiulakis, G., and Roth, M., 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?.The Lancet, Vol. 18. p. 21.
Griffith, D.M., Sharma, G., Holliday, C.S., Enyia, O.K., Valliere, M., Semlow, A.R., Stewart, E.C., and Blumenthal, R.S., 2020. Man and COVID-19: A Biopsychosocial Approarch to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions. Prev Chronic Dis., Vol. 17, No. 63, pp. 1-9
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu,X.,Zhang,Q.,andWu,J., 2020.CoronavirusInfectionsandImmuneResponses.J. Med Virol., pp. 1-9.
Lin, L., Lu, L., Cao, W., Li, T., 2020. Hypothesis for potential pathogenesis of SARSCoV-2 infectiona review of immune changes in patients with viral pneumonia. Emerg Microbes Infect, 2020;9:727-32.
Liu, Z., Bing, X., and Zhi, X.Z., 2020. The Epidemiological Characteristics of an Outbreaks of 2019 Novel Coronavirus Disease (COVID-19) in China. J. Epidemiol Chin., Vol. 41 No. 2, pp. 145-51.
Naaraayan, A., Nimkar, A., Hasan, A., Pant, S., Durdevic, M., Elenius, H., Suarez, C.N., and Jesmajian, S. 2020. Analysis of Male Sex as a Risk Factor in Older Adult with Coronavirus Disease 2019: A Retrospective Cohort Study From the New York City Metropolitan Region. Cureus., Vol. 12, No. 8, pp. 1-13.
Nasiri, M.J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P., Murthi, M., and Mirsaeidi, M., 2020. Covid-19 Clinical Characteristic, and SexSpecific Risk of Mortality: Systemic Review and Meta-Analysis. Front. Med., Vol. 7, No. 459, pp. 1-10.
Nguyen, A.A., Habiballah, S.B., Platt, C.D., Geha, R.S., Chou, J.S., and McDonald,D.R., 2020. Immunoglobulins In The Treatment of COVID-19 Infection: Proceed With Caution. Clin. Immunol., Vol. 216, pp. 1-4.
PDPI, PERKI, PAPDI, PERDATIN, IDAI., 2020. Pedoman Tatalaksana Covid-19, Edisi 2, ISBN: 978-623-92964-8-3, Jakarta.
Shao, Z., Feng, Y., Zhong, L., 2020. Clinical efficacy of intravenous immunoglobulin therapy in critical patients with COVID-19: A multicenter retrospective cohort study. medRxiv. 2020;Preprint. Available at: https://www.medrxiv.org/content/10.1101/2020.04.11.20061739v2
Stockman, L.J., Bellamy, R., and Gaul, P., 2006. SARS: Systematic Review of Treatment Effects.PLoS Med., Vol. 3 No. 9, pp. 1525-31.
Zhou, Y., Yang, Q., Chi, J., Dong, B., Wenshan., Shen, L., and, Wang, Y. 2020. Comorbidities and The Risk of Severe or Fatal Outcomes Associated with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.International J. of Infect Dis. Vol. 99, pp. 47-56.
DOI: https://doi.org/10.22146/farmaseutik.v18i1.71903
Article Metrics
Abstract views : 3773 | views : 30625Refbacks
- There are currently no refbacks.